📢 KIMES 2025 Highlights – Thank You!

Sincere thanks to everyone who came by the PROMEDIUS booth and connected with us at KIMES!

Our first participation in KIMES was a major milestone, made even more special by the recent MFDS (Ministry of Food and Drug Safety) approval of our AI-powered screening tool, PROS® CXR: OSTEO, as a Class II Medical Device.

The KIMES INSPIRE Pavilion provided a great platform to present our technology among other innovators. With around 20 cutting-edge companies presenting their technologies, it served as a powerful glimpse into the future of medical innovation.

The enthusiasm and support we received reaffirm our mission:
"Healthy Aging through AI."
Your engagement motivates us to keep innovating in osteoporosis care and making a real impact in fracture prevention.

We look forward to seeing you again at KIMES Busan this September with even more exciting advancements!